# TigerConnect

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tigerconnect

- Industry: Software
- Headquarters: Santa Monica, US
- Website: www.tigerconnect.com
- Total disclosed funding: $124M
- Latest round: Series D (Oct 8, 2020)
- Investors on record: 13

## About

Based in California, US, and founded in 2010 by CEO Andrew Brooks, and CMO Brad Brooks, TigerConnect, Inc. operates as a health technology company that provides mobile communication solutions to automate team collaboration for the healthcare industry. In January 2022, TigerConnect, Inc. raised USD 300 million in growth capital funding from Vista Equity Partners.

TigerConnect provides secure healthcare communication and collaboration that helps healthcare companies securely communicate across care teams. The company also provides automated physician scheduling software that streamlines shifts and on-call schedule creation for clinics, hospitals, and ambulatory practices. In addition, TigerConnect offers alarm management and event notification, and resident scheduling software to provide actionable notifications at the point of care, and streamline resident and block rotation schedules for returning and new interns, fellows, and residents, respectively.

The company plans to use its proceeds from January 2022 funding to continue its mission to improve patient care through real-time, contextual data and messaging.

## Funding rounds

- Series D, Oct 8, 2020, $45M — Norwest Venture Partners, Montreux Equity Partners, Industry Ventures, New Leaf Venture Partners, Invus [DUP], HealthQuest Capital
- Series C, Nov 11, 2015, $50M — OrbiMed Advisors, Norwest Venture Partners, Shasta Ventures, Accolade Partners, Invus [DUP], REV Venture Partners
- Series B, Jan 27, 2014, $21M — OrbiMed Advisors, Easton Capital Investment Group, Shasta Ventures, TELUS Ventures, New Leaf Venture Partners, New Science Ventures, REV Venture Partners
- Series A, Feb 2, 2012, $8.2M — Easton Capital Investment Group, New Science Ventures

## Investors

- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series A, Series B
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- Shasta Ventures (https://capitalatlas.ai/funds/shasta-ventures) — Series B, Series C
- TELUS Ventures (https://capitalatlas.ai/funds/telus-ventures) — Series B
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B, Series D
- REV Venture Partners (https://capitalatlas.ai/funds/rev-venture-partners) — Series B, Series C
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series C, Series D
- Accolade Partners (https://capitalatlas.ai/funds/accolade-partners) — Series C
- Invus [DUP] — Series C, Series D
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series D
- Industry Ventures (https://capitalatlas.ai/funds/industry-ventures) — Series D
- HealthQuest Capital (https://capitalatlas.ai/funds/healthquest-capital) — Series D